AI assistant
Sending…
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2012
Feb 14, 2012
32130_dirs_2012-02-14_c20574da-0ce7-4708-a16e-9127607f401a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2012-02-13
Reporting Person: MARTIN J TYLER (Director, President, CMO & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-13 | Common shares | A | 150000 | $0.58 | Acquired | 150000 | Direct |
| 2012-02-13 | Common shares | A | 32848 | $1.72 | Acquired | 182848 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-13 | Option (Right to Buy) | $0.58 | M | 75000 | Disposed | 2019-02-26 | Common Stock (75000) | Direct |
| 2012-02-13 | Options (Right to Buy) | $0.58 | M | 75000 | Disposed | 2019-02-26 | Common Stock (75000) | Direct |
| 2012-02-13 | Options (Right to Buy) | $1.72 | M | 32848 | Disposed | 2020-08-24 | Common Stock (32848) | Direct |
Footnotes
F1: Not applicable.
F2: On February 13, 2012, Dr. Martin exercised certain of his outstanding options for cash. No shares were sold in the market in connection with this exercise.
More from DYNAVAX TECHNOLOGIES CORP
Director's Dealing
2026
Feb 11
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10